Bosnia-Herzegovina did not see any initiatives to review OTC status or dosage strengths of certain analgesic categories. Relative to the performance recorded over the review period, analgesics’ performance in 2011 was weaker. This was due to the reduced disposable income of consumers in Bosnia-Herzegovina as a result of the recession.
Euromonitor International's Analgesics in Bosnia-Herzegovina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Analgesics in Bosnia-Herzegovina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Analgesics Company Shares 2007-2011
Table 4 Analgesics Brand Shares 2008-2011
Table 5 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Bosnalijek Pharmaceuticals Dd in Consumer Health (bosnia-herzegovina)
Strategic Direction
Key Facts
Summary 1 Bosnalijek Pharmaceuticals dd: Key Facts
Summary 2 Bosnalijek Pharmaceuticals dd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Bosnalijek Pharmaceuticals dd: Competitive Position 2011
Executive Summary
Emerging Self-medication Trend
Consumers Adapt To Recession
Oligopoly Disappearing
Non-traditional Channels Emerge
Maturation of Consumer Health
Key Trends and Developments
Rx Compared With OTC
Improving Performance of Internationals
Regulation of Vitamins and Dietary Supplements
Potential of the Internet
Merger and Acquisition Activity
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 4 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Analgesics Company Shares 2007-2011
Table 4 Analgesics Brand Shares 2008-2011
Table 5 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Bosnalijek Pharmaceuticals Dd in Consumer Health (bosnia-herzegovina)
Strategic Direction
Key Facts
Summary 1 Bosnalijek Pharmaceuticals dd: Key Facts
Summary 2 Bosnalijek Pharmaceuticals dd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Bosnalijek Pharmaceuticals dd: Competitive Position 2011
Executive Summary
Emerging Self-medication Trend
Consumers Adapt To Recession
Oligopoly Disappearing
Non-traditional Channels Emerge
Maturation of Consumer Health
Key Trends and Developments
Rx Compared With OTC
Improving Performance of Internationals
Regulation of Vitamins and Dietary Supplements
Potential of the Internet
Merger and Acquisition Activity
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 4 Research Sources
